Form D · Pharmaceuticals

China Yongxin Pharmaceuticals Inc.

City Of Industry, CA · CIK 0001087848

Offering snapshot reported Feb 5, 2010 · SEC filing

Reported sold
$900K
Offering amount: $1.5M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 25, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 5, 2010Initial$900,000No comparison9SEC filing
Oct 13, 2009Initial$467,369No comparison156SEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$64K (estimated)
Finders' fees
$0
Form D file number
021-66325
The Company also issued to the Broker a warrant for the right to purchase 120,000 shares of the Company's common stock at the purchase price of $0.50 per share.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
STREETCAPITAL CORP.104034STREETCAPITAL CORP. · CRD 104034

Source: Form D, filed Feb 5, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Yongkui Liu Director
Yongxin Liu Director, Executive
Ning Liu Director, Executive
Umesh Patel Director, Executive
Corp. Streetcapital Promoter
Yongmei Wang Director, Executive
Harry Zhang Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
927 Canada Ct.
City Of Industry, CA, 91748